SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ganga Pharmaceuticals informs about press release

13 Dec 2023 Evaluate
Ganga Pharmaceuticals has informed that it enclosed newspaper Advertisement of Intimation to Hold Extra-Ordinary General Meeting of the Company to be held on Thursday, January 04, 2024 at 2:30 pm published in the following newspapers on December 13, 2023, Financial Express, and Mumbai lakshadeep.

The above information is a part of company’s filings submitted to BSE.

Ganga Pharma. Share Price

12.00 0.00 (0.00%)
12-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.50
Dr. Reddys Lab 1218.45
Cipla 1224.50
Zydus Lifesciences 935.20
Lupin 2350.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×